Trial intelligence / Profile preview

Ketamine Infusion in Mechanically Ventilated ICU Patients

NCT04075006Phase 3Completed

Sponsor
King Faisal Specialist Hospital and Research Centre
Start
Aug 2019
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ketamine in critical illness, sponsored by King Faisal Specialist Hospital and Research Centre. Started Aug 2019; status: completed.

02

Drugs

ketamine
03

Conditions

critical illness

Beyond the preview

Go deeper on NCT04075006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04075006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call